Concord, MA, United States of America

David Hepworth

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 166(Granted Patents)


Location History:

  • Kent, GB (2002)
  • County of Kent, GB (2003)
  • Sandwich, GB (2004 - 2010)
  • Noank, CT (US) (2011)
  • Concord, MA (US) (2014 - 2023)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):

Title: Innovations and Patents of David Hepworth in Pharmaceutical Development

Introduction: David Hepworth is a prominent inventor based in Concord, MA, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 28 patents, Hepworth's innovations focus on the development of chemically advanced compounds aimed at treating various medical conditions.

Latest Patents: Among his latest patents, Hepworth has developed unique bicyclic-fused heteroaryl and aryl compounds. These compounds, along with their tautomers and pharmaceutically acceptable salts, are outlined in detail, wherein the structure is defined within the specification. One application of these compounds is in liquid dosage forms, which can comprise a therapeutically effective amount of the compound or its salt as an adjuvant and therapeutic agent. Another notable invention relates to pyrazole derivatives, focusing on their use in medicine, preparation processes, and intermediates. This specific invention presents HB S modulators, which show promise in treating a variety of disorders, including sickle cell disease (SCD).

Career Highlights: David Hepworth has established his career within the pharmaceutical giant, Pfizer Corporation, where he continues to drive innovation and development in drug discovery and therapeutic applications. His work has not only resulted in numerous patents but has also contributed significantly to advancements in medicinal chemistry.

Collaborations: Hepworth's innovative journey is complemented by collaborations with notable colleagues, including Frank Eldridge Lovering and Joseph Walter Strohbach. Their combined expertise in the field enhances the research and development efforts at Pfizer Corporation.

Conclusion: David Hepworth's extensive experience and accomplishments in the pharmaceutical sector exemplify the impact of innovative thinking in medicine. His patents not only have the potential to address critical health challenges but also pave the way for future inventions in the realm of pharmaceuticals. As he continues to work at Pfizer Corporation, the medical community eagerly anticipates his contributions to advancing healthcare solutions and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…